Prometheus Biosciences, Inc. (RXDX) has a market capitalization of $9.56B and trades at $199.92. The 52-week range is 23.27-199.96.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -57.3, Earnings Per Share (EPS) of $-3.49, annual revenue of $6.81M.
The stock has a beta of -0.49, operates in the Healthcare sector.
